Genomic landscape of MSH6-mutated clinically advanced castrate-resistant prostate cancer (mCRPC).

5062Background: Loss-of-function genomic alterations (GAs) in MSH6 have been associated with a unique subtype of hypermutated mCRPC that is often microsatellite stable (MSS) and may occur in either...